Xilin Wu

919 total citations
24 papers, 582 citations indexed

About

Xilin Wu is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Xilin Wu has authored 24 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 7 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Xilin Wu's work include HIV Research and Treatment (6 papers), Viral Infections and Vectors (6 papers) and Viral Infections and Outbreaks Research (5 papers). Xilin Wu is often cited by papers focused on HIV Research and Treatment (6 papers), Viral Infections and Vectors (6 papers) and Viral Infections and Outbreaks Research (5 papers). Xilin Wu collaborates with scholars based in China, Hong Kong and United States. Xilin Wu's co-authors include Zhiwei Wu, Shijie Xu, Waqas Nawaz, Bilian Huang, Yanlei Li, Linjing Zhu, Nan Zheng, Xiaohua Ma, Yiqiao Hu and Jing Gu and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Frontiers in Immunology.

In The Last Decade

Xilin Wu

23 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xilin Wu China	11	303	137	135	132	92	24	582
Christopher R. Kimberlin United States	11	593 2.0×	133 1.0×	347 2.6×	213 1.6×	186 2.0×	12	984
Randy Foo Singapore	9	839 2.8×	26 0.2×	96 0.7×	115 0.9×	53 0.6×	16	910
István Tombácz United States	7	119 0.4×	83 0.6×	154 1.1×	336 2.5×	28 0.3×	9	460
Xiaoxing Qiu United States	14	149 0.5×	22 0.2×	173 1.3×	82 0.6×	145 1.6×	26	562
Juan Pablo Jaworski Argentina	12	92 0.3×	32 0.2×	264 2.0×	120 0.9×	69 0.8×	22	503
Seraphin Kuate Germany	15	326 1.1×	28 0.2×	263 1.9×	277 2.1×	186 2.0×	22	782
Bang K. Vu United States	13	75 0.2×	79 0.6×	149 1.1×	291 2.2×	72 0.8×	18	506
Richard Hampton United States	6	116 0.4×	57 0.4×	178 1.3×	264 2.0×	48 0.5×	7	500
Emma Bentley United Kingdom	12	284 0.9×	27 0.2×	30 0.2×	113 0.9×	84 0.9×	24	451
Makda S. Gebre United States	10	292 1.0×	105 0.8×	129 1.0×	194 1.5×	126 1.4×	12	586

Countries citing papers authored by Xilin Wu

Since Specialization

Citations

This map shows the geographic impact of Xilin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xilin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xilin Wu more than expected).

Fields of papers citing papers by Xilin Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xilin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xilin Wu. The network helps show where Xilin Wu may publish in the future.

Co-authorship network of co-authors of Xilin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xilin Wu. A scholar is included among the top collaborators of Xilin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xilin Wu. Xilin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Bilian, Shijie Xu, Na Jiang, et al.. (2024). Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody. EMBO Molecular Medicine. 16(3). 575–595. 5 indexed citations

Wu, Xilin, Jingzi Zhang, & Lei Fang. (2024). Next-Generation Sequencing and Proteomics-Enabled Approach for Rapid and High-Throughput Isolation of Virus-Neutralizing Nanobodies. Methods in molecular biology. 2824. 135–146. 2 indexed citations

Zhang, Doudou, et al.. (2024). Structure defining of ultrapotent neutralizing nanobodies against MERS-CoV with novel epitopes on receptor binding domain. PLoS Pathogens. 20(8). e1012438–e1012438. 3 indexed citations

Shi, Sai, Lin Cheng, Binghong Xu, et al.. (2023). Dauricine interferes with SARS-CoV-2 variants infection by blocking the interface between RBD and ACE2. International Journal of Biological Macromolecules. 253(Pt 7). 127344–127344. 3 indexed citations

Wu, Xilin, Yaxin Wang, Lin Cheng, et al.. (2022). Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22). Frontiers in Immunology. 13. 865401–865401. 11 indexed citations

Nawaz, Waqas, Bilian Huang, Shijie Xu, et al.. (2021). AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia. Blood Cancer Journal. 11(6). 119–119. 99 indexed citations

Huang, Bilian, Linjing Zhu, Hongxia Wei, et al.. (2021). Potent Neutralizing Humanized Antibody With Topical Therapeutic Potential Against HPV18-Related Cervical Cancer. Frontiers in Immunology. 12. 2 indexed citations

Xu, Shijie, Na Jiang, Waqas Nawaz, et al.. (2021). Infection of humanized mice with a novel phlebovirus presented pathogenic features of severe fever with thrombocytopenia syndrome. PLoS Pathogens. 17(5). e1009587–e1009587. 32 indexed citations

Wu, Xilin, Lin Cheng, Ming Fu, et al.. (2021). A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration. Cell Reports. 37(3). 109869–109869. 61 indexed citations

10.

Wu, Xilin, Yanlei Li, Bilian Huang, et al.. (2020). A single-domain antibody inhibits SFTSV and mitigates virus-induced pathogenesis in vivo. JCI Insight. 5(13). 38 indexed citations

11.

Nawaz, Waqas, Shijie Xu, Yanlei Li, et al.. (2020). Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy. Acta Biomaterialia. 109. 21–36. 58 indexed citations

12.

Tian, Xiaoyan, Deyan Chen, Huanru Wang, et al.. (2019). The induction and characterization of monoclonal antibodies specific to GP of Ebola virus. Journal of Medical Virology. 92(8). 996–1006.

13.

Wu, Xilin, Jia Guo, Mengyue Niu, et al.. (2018). Tandem bispecific neutralizing antibody eliminates HIV-1 infection in humanized mice. Journal of Clinical Investigation. 128(6). 2239–2251. 38 indexed citations

14.

Song, Peixin, Nan Zheng, Yong Liu, et al.. (2018). Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection. Nature Communications. 9(1). 3328–3328. 104 indexed citations

15.

Wu, Xilin, Li Liu, Ka‐Wai Cheung, et al.. (2016). Brain Invasion by CD4+ T Cells Infected with a Transmitted/Founder HIV-1BJZS7 During Acute Stage in Humanized Mice. Journal of Neuroimmune Pharmacology. 11(3). 572–583. 23 indexed citations

16.

Cheng, Lin, Xian Tang, Li Liu, et al.. (2015). Monoclonal antibodies specific to human Δ42PD1: A novel immunoregulator potentially involved in HIV-1 and tumor pathogenesis. mAbs. 7(3). 620–629. 5 indexed citations

17.

Guo, Jia, Teng Zuo, Lin Cheng, et al.. (2015). Simian Immunodeficiency Virus Infection Evades Vaccine-Elicited Antibody Responses to V2 Region. JAIDS Journal of Acquired Immune Deficiency Syndromes. 68(5). 502–510. 4 indexed citations

18.

Wang, Lianhong, et al.. (2015). Prevalence of Consistent Condom Use with Various Types of Sex Partners and Associated Factors among Money Boys in Changsha, China. The Journal of Sexual Medicine. 12(4). 936–945. 6 indexed citations

19.

Chu, Ying, Jiahuang Li, Xilin Wu, Zichun Hua, & Zhiwei Wu. (2013). Identification of human immunodeficiency virus type 1 (HIV-1) gp120-binding sites on scavenger receptor cysteine rich 1 (SRCR1) domain of gp340. Journal of Biomedical Science. 20(1). 44–44. 8 indexed citations

20.

Lau, Joseph T. F., Chunqing Lin, Chun Hao, Xilin Wu, & Jing Gu. (2011). Public health challenges of the emerging HIV epidemic among men who have sex with men in China. Public Health. 125(5). 260–265. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact